Earnings Data
Report Date
Nov 05, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
1.65Last Year’s EPS
-0.54Same Quarter Last Year
Strong Buy
Based on 11 Analysts Ratings
DE:PGF Q2 2026 Earnings Report
DE:PGF Upcoming Earnings
Protagonist Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
DE:PGF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:PGF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2026 | €75.00 | €75.00 | 0.00% |
May 05, 2026 | €75.00 | €75.00 | 0.00% |
Feb 25, 2026 | €75.00 | €75.00 | 0.00% |
Nov 06, 2025 | €68.50 | €68.00 | -0.73% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Protagonist Therapeutics (DE:PGF) report earnings?
Protagonist Therapeutics (DE:PGF) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).
What is Protagonist Therapeutics (DE:PGF) earnings time?
Protagonist Therapeutics (DE:PGF) earnings time is at Nov 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Protagonist Therapeutics stock?
The P/E ratio of Protagonist Therapeutics is N/A.
What is DE:PGF EPS forecast?
DE:PGF EPS forecast for the fiscal quarter 2026 (Q3) is 1.65.